Mesa Laboratories acquires Gyros Protein Technologies

Mesa Laboratories, Inc. has acquired 100% of the shares in Gyros Protein Technologies AB for a total consideration of USD 180 million, subject to purchase price adjustments. Gyros Protein Technologies was acquired from AP6 (the Sixth Swedish National Pension Fund acting through SLS Invest AB), Ampersand Capital Partners and various minority shareholders.

Gyros Protein Technologies, with headquarters in Uppsala, Sweden, is a leading provider of immunoassay and peptide synthesis solutions that accelerate the discovery, development and manufacturing of biotherapeutics.

Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries.

Mesa was advised by Mannheimer Swartling in the transaction together with the US law firm Davis Graham & Stubbs.


This website uses cookies to perform certain functions and help you navigate the site efficiently. A cookie is a text file with a small amount of information that is stored on your device. We share some of the information we obtain through these cookies with third parties. We only use cookies that are necessary for the site to function correctly and they therefore cannot be turned off. For further information, see Information on the use of cookies.